Video

Q&A With Diego Cadavid, MD, FAAN, of Biogen: Anti-Lingo-1 for Optic Neuritis Treatment

Author(s):

As one of the first signs of multiple sclerosis acute optic neuritis can be a worrying symptom for patients. Finding the proper treatment can be important in the early stages of diagnosis.

As one of the first signs of multiple sclerosis acute optic neuritis can be a worrying symptom for patients. Finding the proper treatment can be important in the early stages of diagnosis.

Diego Cadavid, MD, FAAN, from Biogen International discussed the effects of Anti-LINGO-1 in the treatment of Acute Optic Neuritis and the results of the RENEW Trial during the American Academy of Neurology's annual meeting in Washington DC.

Related Videos
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
Nathan D. Wong, MD, PhD: Growing Role of Lp(a) in Cardiovascular Risk Assessment | Image Credit: UC Irvine
Laurence Sperling, MD: Expanding Cardiologists' Role in Obesity Management  | Image Credit: Emory University
Laurence Sperling, MD: Multidisciplinary Strategies to Combat Obesity Epidemic | Image Credit: Emory University
Schafer Boeder, MD: Role of SGLT2 Inhibitors and GLP-1s in Type 1 Diabetes | Image Credit: UC San Diego
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Alice Cheng, MD: Exploring the Link Between Diabetes and Dementia | Image Credit: LinkedIn
© 2024 MJH Life Sciences

All rights reserved.